Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL 14736, Pliva) Current Pharmaceutical Design Comprehensive review of BPC 157 clinical development for inflammatory bowel disease including ulcerative colitis trials, demonstrating mucosal healing and anti-inflammatory effects across multiple organ systems
P21 promotes the formation and strengthening of synaptic connections, enhancing the brain's capacity for learning and memory through structural changes rather than temporary neurochemical modulation
Reconstitute with bacteriostatic water for research handling
In experimental colitis models, for example, BPC-157 administration was associated with: BPC-157 also promotes angiogenesis (blood vessel growth) and stabilizes vascular function at sites of injury
Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats
US$ 25.70
US$ 27.83
US$ 27.69
US$ 23.70
US$ 26.52
US$ 24.59
US$ 29.37
US$ 21.26
US$ 25.59
US$ 25.03
US$ 28.41
